Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

QMED Insider Trading

QMED | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at QMED provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2007-11-08 20:24 2007-11-06 KRAF TERI J Officer - Senior Vice President SELL $0.26 305,194 $80,052 1,097,914 -21.8%
2007-08-23 20:38 2007-08-21 SIEGEL JOHN W Officer - Sr. VP BUY $3.11 3,000 $9,327 25,700 +13.2%
2007-08-23 20:33 2007-08-21 MURRAY JANE Director, Officer - CEO, President & COO BUY $3.11 3,000 $9,327 5,500 +120.0%
2007-08-18 01:03 2007-08-17 SCHMITT WILLIAM Officer - SR. VP, CFO & Treasurer BUY $3.03 1,000 $3,029 2,000 +100.0%
2007-06-21 16:56 2007-06-19 MOSBY ROBERT Officer - Vice President BUY $3.18 400 $1,272 6,650 +6.4%
2007-01-30 03:09 2007-01-19 KRAF TERI J Officer - Senior Vice President OPT+S $4.31 41,974 $180,971 1,477,334 0.0%
2007-01-30 03:08 2007-01-18 KRAF TERI J Officer - Senior Vice President OPT+S $4.51 27,000 $121,900 1,404,608 0.0%
2007-01-30 03:07 2007-01-19 COX MICHAEL W Director OPT+S $4.31 41,974 $180,971 1,481,834 0.0%
2007-01-30 03:05 2007-01-18 COX MICHAEL W Director OPT+S $4.51 27,000 $121,900 1,409,108 0.0%
2007-01-20 00:26 2007-01-17 KRAF TERI J Officer - Senior Vice President OPT+S $4.61 32,800 $151,316 1,404,608 0.0%
2007-01-20 00:25 2007-01-17 COX MICHAEL W Director OPT+S $4.62 31,000 $143,108 1,409,108 0.0%
2007-01-19 01:52 2007-01-16 KRAF TERI J Officer - Senior Vice President OPT+S $4.89 25,500 $124,759 1,404,608 0.0%
2007-01-19 01:50 2007-01-16 COX MICHAEL W Director OPT+S $4.89 25,500 $124,759 1,409,108 0.0%
2006-07-31 21:38 2006-07-27 Burt K Randall Officer - Pres of a Qmed, Inc Subsidiary BUY $3.11 1,000 $3,106 98,134 +1.0%
2006-07-13 16:14 2006-07-11 SIEGEL JOHN W Officer - Sr. VP BUY $3.25 2,500 $8,125 22,700 +12.4%
2006-07-13 19:53 2006-07-11 KRAF TERI J Officer - Senior Vice President BUY $3.25 2,500 $8,125 44,530 +5.9%
2006-07-13 16:13 2006-07-11 MURRAY JANE Director, Officer - COO & EVP BUY $3.25 2,500 $8,125 2,500 +100.0%
2006-07-13 16:01 2006-07-11 COX MICHAEL W Director, Officer, 10% owner - President and CEO BUY $3.25 2,500 $8,125 1,413,108 +0.2%
2006-07-12 20:54 2006-07-11 SCHMITT WILLIAM Officer - SR. VP, CFO & Treasurer BUY $3.20 1,000 $3,200 1,000 +100.0%
2006-06-23 20:21 2006-06-22 MOSBY ROBERT Officer - Vice President BUY $4.42 1,000 $4,418 7,250 +16.0%
2006-06-23 20:24 2006-06-22 KRAF TERI J Officer - Senior Vice President BUY $4.38 2,000 $8,758 42,030 +5.0%
2006-06-23 20:26 2006-06-22 COX MICHAEL W Director, Officer, 10% owner - President and CEO BUY $4.38 2,000 $8,758 1,410,608 +0.1%
2006-04-25 20:24 2006-04-24 LEVIN RICHARD I Director SELL $6.36 23,000 $146,248 60,000 -27.7%
2005-10-25 21:39 2005-10-21 SIEGEL JOHN W Officer - Sr. VP SELL $10.62 10,000 $106,200 0 -100.0%
2005-10-25 21:37 2005-10-21 MURRAY JANE Director, Officer - COO & EVP SELL $10.62 10,000 $106,200 0 -100.0%
2005-07-28 21:50 2005-07-21 SIEGEL JOHN W Officer - Sr. VP SELL $10.70 16,001 $171,243 10,000 -61.5%
2005-07-26 00:30 2005-07-21 MURRAY JANE Director, Officer - COO & EVP SELL $10.70 16,001 $171,243 10,000 -61.5%
2005-07-22 22:49 2005-07-20 SIEGEL JOHN W Officer - Sr. VP SELL $10.74 5,500 $59,070 200 -96.5%
2005-07-22 22:48 2005-07-20 MURRAY JANE Director, Officer - COO & EVP SELL $10.74 5,500 $59,070 0 -100.0%
2005-07-18 18:26 2005-07-14 MOSBY ROBERT Officer - Vice President SELL $10.90 2,450 $26,705 0 -100.0%
2005-07-19 00:01 2005-07-12 LEVIN RICHARD I Director SELL $10.50 10,000 $105,000 83,000 -10.8%
2005-07-08 17:49 2005-07-06 KRAF TERI J Officer - Senior Vice President SELL $10.21 8,257 $84,304 42,030 -16.4%
2005-07-07 15:52 2005-07-06 COX MICHAEL W Director, Officer, 10% owner - President and CEO SELL $10.21 38,000 $387,980 1,410,608 -2.6%
2005-06-21 20:28 2005-06-16 KRAF TERI J Officer - Senior Vice President BUY $2.75 20,000 $55,000 52,287 +61.9%
2005-05-17 20:57 2005-05-17 LEVIN RICHARD I Director BUY $2.25 70,000 $157,500 93,000 +304.3%
2005-03-17 23:01 2005-03-07 GRANT WILLIAM R Other BUY $11.00 59,800 $657,800 2,870,993 +2.1%
2005-02-28 22:13 2005-02-24 LEVIN RICHARD I Director SELL $10.04 16,000 $160,659 23,000 -41.0%
2004-12-22 03:01 2004-12-21 LEVIN RICHARD I Director SELL $11.50 7,000 $80,509 39,000 -15.2%
2004-12-07 00:12 2004-12-03 LEVIN RICHARD I Director SELL $13.65 800 $10,922 46,000 -1.7%
2004-11-03 23:58 2004-11-03 LEVIN RICHARD I Director SELL $8.14 10,000 $81,400 16,800 -37.3%
2004-06-11 04:57 2004-06-09 LEVIN RICHARD I Director SELL $9.35 10,000 $93,468 26,800 -27.2%
2004-06-08 02:55 2004-06-03 KRAF TERI J Officer - Senior Vice President SELL $10.21 6,713 $68,559 15,287 -30.5%
2004-06-08 02:55 2004-06-03 COX MICHAEL W Director, Officer, 10% owner - President and CEO SELL $10.21 6,713 $68,559 15,287 -30.5%
2004-04-23 23:20 2004-04-22 LEVIN RICHARD I Director SELL $10.70 4,000 $42,805 38,503 -9.4%
2004-03-10 01:20 2004-03-08 LEVIN RICHARD I Director OPT+S $10.33 9,200 $94,999 42,503 0.0%
2003-09-09 23:49 2003-09-05 LEVIN RICHARD I Director SELL $7.26 21,911 $159,072 21,703 -50.2%
SHOW ENTRIES

How to Interpret $QMED Trades

Not every insider transaction in QMED is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $QMED shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for QMED

Insider activity data for QMED is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $QMED, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.